Monday, January 13, 2020

Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential

CD47, the integrin-related protein, plays an important role in immune resistance and escape of tumor cells. Antibodies blocking the CD47/SIRPα signal pathway can effectively stimulate macrophage-mediated phago...

from Most Recent Articles: Journal of Nanobiotechnology https://ift.tt/35HtsAM
via IFTTT

No comments:

Post a Comment